Mazen Hanna reports financial support was provided by Pfizer Inc, Alnylam Pharmaceuticals Inc, Bridgebio Pharma Inc, Ionis, and by the Cleveland Clinic Term Chair in Amyloid Heart Disease Research. Alexion Pharmaceuticals Inc. Deborah Kwon reports financial support was provided by National Heart Lung and Blood Institute and Circle CVI42. Milind Desai reports financial support was provided by Bristol Myers Squibb Co, Tenaya Therapeutics, Cytokinetics Inc, Liz, AI, Edgewise Therapeutics, Inc, and